Using these models, we demonstrated that all fibroblastomas except that induced by V600E exhibited a strong resistance to plx4720 albeit sensitivity to plx8394 with different extents (Figure 3C-D), suggesting that indeed RAF dimer breakers associating with a DFG-out conformation may serve as a therapeutic option for treating cancer patients harboring these BRAF mutations. This evidence concerns the gene RAF1 and cancer.